News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
861,799 Results
Type
Article (87483)
Company Profile (807)
Press Release (773487)
Multimedia
Podcasts (175)
Webinars (28)
Section
Business (233074)
Career Advice (4140)
Deals (39802)
Drug Delivery (138)
Drug Development (91267)
Employer Resources (203)
FDA (18289)
Job Trends (17403)
News (397440)
Policy (39927)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (127)
Alliances (56980)
ALS (147)
Alzheimer's disease (1687)
Antibody-drug conjugate (ADC) (257)
Approvals (18324)
Artificial intelligence (504)
Autoimmune disease (93)
Automation (28)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (163)
Biotechnology (485)
Bladder cancer (136)
Brain cancer (53)
Breast cancer (514)
Cancer (4069)
Cardiovascular disease (353)
Career advice (3560)
Career pathing (38)
CAR-T (251)
CDC (57)
Cell therapy (696)
Cervical cancer (33)
Clinical research (75679)
Collaboration (1420)
Company closure (4)
Compensation (943)
Complete response letters (60)
COVID-19 (2961)
CRISPR (82)
C-suite (609)
Cystic fibrosis (140)
Data (4709)
Decentralized trials (2)
Denatured (63)
Depression (112)
Diabetes (459)
Diagnostics (7100)
Digital health (37)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (240)
Drug pricing (192)
Drug shortages (36)
Duchenne muscular dystrophy (205)
Earnings (98959)
Editorial (54)
Employer branding (25)
Employer resources (172)
Events (133192)
Executive appointments (996)
FDA (20819)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (1281)
Gene editing (175)
Generative AI (51)
Gene therapy (555)
GLP-1 (1026)
Government (5387)
Grass and pollen (7)
Guidances (360)
Healthcare (20938)
HIV (48)
Huntington's disease (40)
IgA nephropathy (64)
Immunology and inflammation (245)
Immuno-oncology (21)
Indications (55)
Infectious disease (3210)
Inflammatory bowel disease (191)
Inflation Reduction Act (16)
Influenza (102)
Intellectual property (193)
Interviews (816)
IPO (17928)
IRA (59)
Job creations (5197)
Job search strategy (2865)
Kidney cancer (17)
Labor market (80)
Layoffs (641)
Leadership (36)
Legal (10148)
Liver cancer (92)
Longevity (13)
Lung cancer (585)
Lymphoma (269)
Machine learning (31)
Management (66)
Manufacturing (652)
MASH (143)
Medical device (14893)
Medtech (14918)
Mergers & acquisitions (22766)
Metabolic disorders (1171)
Multiple sclerosis (139)
NASH (23)
Neurodegenerative disease (234)
Neuropsychiatric disorders (63)
Neuroscience (2741)
NextGen: Class of 2025 (7687)
Non-profit (5096)
Now hiring (59)
Obesity (564)
Opinion (315)
Ovarian cancer (137)
Pain (170)
Pancreatic cancer (176)
Parkinson's disease (244)
Partnered (30)
Patents (424)
Patient recruitment (327)
Peanut (57)
People (66313)
Pharmaceutical (145)
Pharmacy benefit managers (28)
Phase I (23344)
Phase II (32844)
Phase III (24761)
Pipeline (2781)
Policy (296)
Postmarket research (3554)
Preclinical (10535)
Press Release (72)
Prostate cancer (204)
Psychedelics (52)
Radiopharmaceuticals (282)
Rare diseases (690)
Real estate (7422)
Recruiting (79)
Regulatory (28076)
Reports (65)
Research institute (2693)
Resumes & cover letters (651)
Rett syndrome (16)
RNA editing (15)
RSV (76)
Schizophrenia (138)
Series A (213)
Series B (159)
Service/supplier (30)
Sickle cell disease (81)
Special edition (26)
Spinal muscular atrophy (170)
Sponsored (41)
Startups (4319)
State (2)
Stomach cancer (17)
Supply chain (102)
Tariffs (96)
The Weekly (110)
Vaccines (1057)
Venture capital (67)
Weight loss (399)
Women's health (60)
Worklife (21)
Date
Today (188)
Last 7 days (750)
Last 30 days (2862)
Last 365 days (33593)
2025 (27335)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1280)
Alabama (80)
Alaska (7)
Arizona (307)
Arkansas (14)
Asia (51026)
Australia (8969)
California (9648)
Canada (2896)
China (924)
Colorado (406)
Connecticut (430)
Delaware (276)
Europe (117230)
Florida (1418)
Georgia (318)
Hawaii (3)
Idaho (67)
Illinois (819)
India (54)
Indiana (476)
Iowa (20)
Japan (330)
Kansas (125)
Kentucky (39)
Louisiana (22)
Maine (78)
Maryland (1293)
Massachusetts (7227)
Michigan (317)
Minnesota (572)
Mississippi (4)
Missouri (122)
Montana (33)
Nebraska (26)
Nevada (109)
New Hampshire (79)
New Jersey (2678)
New Mexico (32)
New York (2617)
North Carolina (1424)
North Dakota (10)
Northern California (4402)
Ohio (303)
Oklahoma (22)
Oregon (51)
Pennsylvania (1999)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (50)
South Dakota (1)
Southern California (3680)
Tennessee (151)
Texas (1521)
United States (35559)
Utah (285)
Virginia (250)
Washington D.C. (84)
Washington State (826)
West Virginia (4)
Wisconsin (98)
Wyoming (1)
There are 861,799 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Transcat to Attend Upcoming Investor Conferences in November 2025
October 29, 2025
·
3 min read
Press Releases
Lantern Pharma Presents LP-284 Clinical Data at 25th LL&M Congress, Highlighting Complete Response in Therapeutically Exhausted DLBCL Patient & Therapeutic Potential in Advanced B-Cell Cancers.
October 29, 2025
·
11 min read
Press Releases
Slingshot Biosciences and Cellares Combine TruCytes™ Biomarker Controls with the Cell Q™ Platform to Enhance Quality and Automation in Cell Therapy Manufacturing
October 29, 2025
·
4 min read
Press Releases
Enigma Biomedical USA announces FDA Acceptance of New Drug Application for florquinitau F-18 (MK-6240), a Tau PET Alzheimer’s Disease radiodiagnostic
October 29, 2025
·
5 min read
Press Releases
Publication of Landmark Study in JACC: Advances
October 29, 2025
·
2 min read
Mergers & acquisitions
5 SMID-Cap Pharmas Poised for M&A Action
Mergers and acquisitions are not just for Big Pharma. A new report from Leerink Partners takes a stab at identifying the small- to mid-cap pharmas best prepared to bolster their pipelines with a buyout.
October 29, 2025
·
7 min read
·
Annalee Armstrong
Press Releases
Genprex Announces Registered Direct Offering of up to $10.0 Million Priced At-The-Market Under Nasdaq Rules
October 29, 2025
·
6 min read
Press Releases
Merck Partners with Promega to Advance 3-D Cell Drug Discovery Technologies
October 28, 2025
·
4 min read
Press Releases
BostonGene to Present Omnimodal Foundation AI for Cancer and the Immune System at SITC 2025 Annual Meeting
October 28, 2025
·
2 min read
Press Releases
Syncell Launches Ultra-High-Precision Photolabeling Kit for Nanoscopic Proteomic Discovery
October 28, 2025
·
3 min read
1 of 86,180
Next
